MRVI Maravai Lifesciences Holdings, Inc. - 8-K

Item 5.07. Submission of Matters to a Vote of Security Holders.

On May 26, 2026, Maravai LifeSciences Holdings, Inc. (the “Company”) held its 2026 Annual Meeting of Shareholders (the “Annual Meeting”). On March 27, 2026, the record date for the Annual Meeting, the Company had an aggregate of 258,180,170 shares of common stock outstanding, consisting of 147,496,090 shares of Class A common stock and 110,684,080 shares of Class B common stock (together, the “Common Stock”). The holders of a total of 236,082,968 shares of Common Stock were present at the Annual Meeting, either in person or by proxy, which constituted a quorum for the purpose of conducting business at the Annual Meeting.

Set forth below are the final voting results for each proposal submitted to a vote of the Company’s shareholders at the Annual Meeting.

Proposal No. 1: Election of directors.

The Company’s shareholders elected the following nominees for director to serve for three-year terms expiring at the Company’s 2029 Annual Meeting of Shareholders and until their respective successors are duly elected and qualified, or until his or her earlier death, resignation or removal.

Nominee

Votes For

Votes Withheld

Broker Non-Votes

Bernd Brust

182,998,545.00

19,825,453.49

33,258,969.51

Gregory T. Lucier

179,514,826.00

23,309,172.49

33,258,969.51

Luke Marker

182,239,834.00

20,584,164.49

33,258,969.51

Proposal No. 2: Proposal to ratify the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026.

The appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026 was ratified by the Company’s shareholders.

Votes For

Votes Against

Abstentions

234,492,897.00

1,246,939.00

343,132.00

Proposal No. 3: Proposal to approve, on a non-binding advisory basis, the compensation of the Company's named executive officers, as disclosed in the Company's proxy statement for the Annual Meeting.

The Company’s shareholders approved, on a non-binding and advisory basis, the compensation of the Company’s named executive officers, as disclosed in the Company’s proxy statement for the Annual Meeting.

Votes For

Votes Against

Abstentions

Broker Non-Votes

200,054,156.49

2,457,403.00

312,439.00

33,258,969.51